Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Multiple Sclerosis 2Skin Neoplasms 1Multiple Sclerosis, Relapsing-Remitting 1Melanoma 1Lymphopenia 1Glioblastoma 1Carcinoma, Basal Cell 1Breast Neoplasms 1Astrocytoma 1

Interventions

Interferon beta-1b 2Fingolimod Hydrochloride 2teriflunomide 1nabiximols 1Platelet Transfusion 1OM 89 1Natalizumab 1Mn-PyC3A 1Magnetic Resonance Imaging 1Interferon beta-1a 1Fish Oils 1Dimethyl Fumarate 1Blood Specimen Collection 1Alemtuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Multiple Sclerosis × Fingolimod Hydrochloride × Clear all
NCT06705608 2024-11-26

MS; FTY720

University of British Columbia

Completed
4,000 enrolled
Dermatologic

Carcinoma, Basal Cell, Melanoma, Multiple Sclerosis, Skin Neoplasms, Multiple Sclerosis, Relapsing-Remitting

NCT02939079 2019-05-14

Evaluating of the Effect of Fingolimod With Fish Oil on Relapsing-Remitting Multiple Sclerosis Patients

Isfahan University of Medical Sciences

Phase 2/3 Completed
50 enrolled 20 charts

Multiple Sclerosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡